Middle East and Africa Respiratory Monitoring Market Size

MEA Respiratory Monitoring Market Analysis

The Middle East and Africa Respiratory Monitoring Market size is estimated at USD 139.47 million in 2024, and is expected to reach USD 191.26 million by 2029, growing at a CAGR of 6.52% during the forecast period (2024-2029).

The COVID-19 pandemic accelerated the demand for respiratory monitors worldwide as the disease causes severe respiratory syndrome. The South African healthcare system was majorly impacted during the pandemic due to delays in precautions taken by the South African government, lack of PPE kits, and other COVID-related equipment, such as spirometers and pulse oximeters. However, at the peak of the COVID-19 pandemic, when the number of sufferers increased drastically, there was an immediate increase in the production, import, and deployment of respiratory products, such as pulse oximeters, ventilators, and other devices. Thus, the market studied witnessed significant growth during the pandemic. However, post-covid, there was a slight decrease in the demand for respiratory monitoring devices, and the market has currently reached the pre-pandemic level. It is believed to witness healthy growth in the coming years.

In recent years, the awareness regarding disorders and their management drastically improved in developing regions, such as the Middle East and Africa. The development of advanced technologies also helps market growth in the region. More importantly, economic development in the region led to increased pollution levels in cities, exacerbating chronic respiratory illnesses. These factors help market growth in the region.

The increasing burden of respiratory diseases across the region propels the market growth. For instance, as stated by the NSW government, as of 2021, a total of 2,578 laboratory-confirmed cases of Middle East respiratory syndrome (MERS) were documented internationally. Saudi Arabia reported the most cases, with 2,178 cases and 810 associated deaths. Furthermore, the rising prevalence of COPD across the region augments the demand for respiratory monitoring, thus contributing to market growth. For instance, the National Health Institute's article published in March 2022 suggests that the prevalence of COPD in sub-Saharan Africa was around 24% in 2021. Hence, owing to rising respiratory diseases in the region, the market studied is believed to grow in the future.

However, reimbursement concerns regarding respiratory monitoring devices are expected to hinder the market growth.